Ken Griffin’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.5K Buy
60,851
+26,456
+77% +$36.1K ﹤0.01% 12320
2025
Q4
$39.2K Sell
34,395
-75,078
-69% -$77.3K ﹤0.01% 12140
2025
Q3
$126K Buy
109,473
+78,302
+251% +$96.3K ﹤0.01% 11668
2025
Q2
$27.5K Sell
31,171
-43,077
-58% -$43.9K ﹤0.01% 12014
2025
Q1
$73.5K Buy
74,248
+6,595
+10% +$9.32K ﹤0.01% 11855
2024
Q4
$114K Buy
67,653
+17,377
+35% +$28.7K ﹤0.01% 11277
2024
Q3
$88K Buy
50,276
+8,918
+22% +$17.5K ﹤0.01% 11290
2024
Q2
$89.3K Buy
41,358
+2,458
+6% +$6.58K ﹤0.01% 11073
2024
Q1
$116K Buy
38,900
+31,869
+453% +$86.1K ﹤0.01% 11154
2023
Q4
$19.8K Buy
7,031
+6,932
+7,002% +$18.2K ﹤0.01% 12631
2023
Q3
$251 Sell
99
-10,943
-99% -$20.8K ﹤0.01% 14113
2023
Q2
$24K Sell
11,042
-1,181
-10% -$2.59K ﹤0.01% 12573
2023
Q1
$25.4K Buy
12,223
+2,990
+32% +$6.61K ﹤0.01% 12871
2022
Q4
$18.6K Buy
+9,233
New +$20.5K ﹤0.01% 13203
2021
Q3
Sell
-13,104
Closed -$92K 14220
2021
Q2
$92K Buy
+13,104
New +$99.5K ﹤0.01% 12980

Other funds holding IRIX

Ken Griffin's IRIX Position: Q1 2026 in Review

Ken Griffin increased its IRIDEX (IRIX) stake by 77% in Q1 2026, buying an estimated $36.1K and bringing the position to 60,851 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12320.

Ken Griffin first reported a position in IRIX in Q2 2021 and has held it in 15 quarters since. The position peaked at $126K in Q3 2025. 25 funds tracked by Wall St. Rank hold IRIX as of Q1 2026.

  • Ken Griffin held 60,851 shares of IRIDEX worth $61.5K as of Q1 2026.
  • Ken Griffin bought 26,456 IRIDEX shares in Q1 2026, an estimated $36.1K.
  • IRIDEX made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12320 holding.
  • Ken Griffin first reported a position in IRIDEX in Q2 2021 and has held it in 15 quarters since.
  • Ken Griffin's IRIDEX position peaked at $126K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held IRIDEX as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.